Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 340,522 | 451,501 | 256,380 | 254,568 | 348,930 |
| Marketable Securities | 20,385 | 388 | 40,602 | 36,592 | N/A |
| Receivables | 12,099 | 20,144 | 12,277 | 12,350 | 16,808 |
| Inventories | 2,897 | 275 | 250 | 118 | 175 |
| Other current assets | 15,617 | 15,333 | 13,712 | 8,870 | 5,202 |
| TOTAL | $391,520 | $487,641 | $323,221 | $312,498 | $371,116 |
| Non-Current Assets | |||||
| PPE Net | 23,712 | 10,041 | 7,226 | 16,900 | 5,600 |
| Intangibles | 1,108 | 1,268 | 1,431 | 1,343 | 1,062 |
| Other Non-Current Assets | 51,129 | 1,891 | 1,004 | 691 | 938 |
| TOTAL | $75,949 | $13,200 | $9,661 | $18,934 | $7,600 |
| Total Assets | $467,469 | $500,840 | $332,882 | $331,432 | $378,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 21 | 1,730 | 2,133 |
| Accounts payable and accrued liabilities | 29,264 | 15,883 | 9,460 | 9,722 | 7,341 |
| Other current liabilities | 12,240 | 9,899 | 7,997 | 5,790 | 15,157 |
| TOTAL | $62,604 | $46,869 | $45,453 | $56,171 | $85,434 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,018 | 13 | 30 | 73 |
| Deferred Revenues | 20,033 | 20,754 | 27,975 | 38,929 | 60,803 |
| Other Non-Current Liabilities | 62,516 | 12,321 | 7,745 | 560 | 295 |
| TOTAL | $49,395 | $3,699 | $3,443 | $590 | $559 |
| Total Liabilities | $111,999 | $50,568 | $48,897 | $56,761 | $85,993 |
| Shareholders' Equity | |||||
| Common Shares | 2,767 | 2,765 | 2,367 | 2,332 | 1,953 |
| Retained earnings | -508,481 | -405,321 | -353,070 | -275,130 | -175,146 |
| Other shareholders' equity | 17,706 | 24,303 | 20,651 | -20,716 | -1,210 |
| TOTAL | $355,470 | $450,272 | $283,985 | $274,671 | $292,723 |
| Total Liabilities And Equity | $467,469 | $500,840 | $332,882 | $331,432 | $378,715 |